Katherine Stueland, Chief Executive Officer at GeneDx Holdings Corp. (WGS), sold 3,220 shares at $93.00 ($299K) on 2025-07-09, disclosed to the SEC on 2025-07-11.
Scheduled sale ($299k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |